Roche is an innovation company pioneering the future of healthcare, science and R&D.
Our scientists are amongst the best in the industry, discovering and translating cutting-edge science in the pursuit of delivering life-changing benefits to patients. We continue to be driven by our long-term aim to deliver these medical advances that provide greater benefits to patients, and at the same time, reduce the healthcare burden on society.
Roche Pharma Research and Early Development (pRED) scientists are active members of the scientific community and publish in numerous peer-reviewed journals in the areas of Clinical Development, Immunology, Infectious diseases and Ophthalmology, Neuroscience and Rare Diseases, Oncology, Pharmaceutical Sciences, Therapeutic Modalities and Translational Bioengineering.